Theratechnologies (Theratechnologies) Long-Term Capital Lease Obligation : $0.46 Mil (As of Feb. 2024)

View and export this data going back to 2011. Start your Free Trial

What is Theratechnologies Long-Term Capital Lease Obligation?

Theratechnologies's Long-Term Capital Lease Obligation for the quarter that ended in Feb. 2024 was $0.46 Mil.

Theratechnologies's quarterly Long-Term Capital Lease Obligation declined from Aug. 2023 ($0.68 Mil) to Nov. 2023 ($0.57 Mil) and declined from Nov. 2023 ($0.57 Mil) to Feb. 2024 ($0.46 Mil).

Theratechnologies's annual Long-Term Capital Lease Obligation declined from Nov. 2021 ($2.06 Mil) to Nov. 2022 ($1.45 Mil) and declined from Nov. 2022 ($1.45 Mil) to Nov. 2023 ($0.57 Mil).

Theratechnologies Long-Term Capital Lease Obligation Historical Data

The historical data trend for Theratechnologies's Long-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Theratechnologies Long-Term Capital Lease Obligation Chart

Theratechnologies Annual Data

Trend

Nov14

Nov15

Nov16

Nov17

Nov18

Nov19

Nov20

Nov21

Nov22

Nov23

Long-Term Capital Lease Obligation

Get a 7-Day Free Trial

2.56

2.06

1.45

0.57

Theratechnologies Quarterly Data
	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24
Long-Term Capital Lease Obligation	Get a 7-Day Free Trial															0.59	0.80	0.68	0.57	0.46

Theratechnologies (NAS:THTX) Long-Term Capital Lease Obligation Explanation

Long-Term Capital Lease Obligation are the amount due for long-term asset lease agreements that are nearly equivalent to asset purchases. Capital lease obligations are installment payments that constitute a payment of principal plus interest for the capital lease. The Short-Term Capital Lease Obligation is the portion of a Long-Term Capital Lease Obligation that is due over the next year.

Under US Generally Accepted Accounting Principles (GAAP), a capital lease is essentially equivalent to a purchase by the lessee if it meets the following criteria:

1. Ownership of the asset is transferred to the lessee at the end of the lease term;
2. The lease contains a bargain purchase option to buy the equipment at less than fair market value;
3. The lease term equals or exceeds 75% of the asset's estimated useful life;
4. The present value of the lease payments equals or exceeds 90% of the total original cost of the equipment.

Theratechnologies Long-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Theratechnologies's Long-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Theratechnologies (Theratechnologies) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Theratechnologies Inc (NAS:THTX) » Definitions » Long-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

TQ80:Germany TH:Canada

Address

2015, rue Peel, 11e etage, Montreal, QC, CAN, H3A 1T8

Website

https://www.theratech.com

Theratechnologies Inc is a specialty pharmaceutical company that addresses the unmet medical needs of HIV patients. It mainly operates in Canada and the United States. The company has two approved products, EGRIFTA marketed in Canada and the United States, and Trogarzo approved for commercialization in the United States.